Trading Performance
Ascentage Pharma Group (ticker 6855.HK) closed up 2.76 % during the 24‑hour period ending at 11:39 AM Central Europe on Wednesday, 21 October 2023. The share price was HKD 31.26 at the time of reporting.
- Current market capitalization: HKD 11.7 billion
- Total shares outstanding: 373.6 million
- Volume traded in the last 24 hours: HKD 86.4 million
- Simple moving average (200 days): HKD 40.34
- 52‑week high: HKD 69.95 (27 October 2025)
- 52‑week low: HKD 27.12 (9 October 2026)
The stock has declined 3.6 % since the previous month‑end.
Comparative Performance of Related Stocks
| Stock | Ticker | 24‑hour change | Current price | Market cap (CNY) | P/E ratio |
|---|---|---|---|---|---|
| China National Gold | 600916.SS | 0 % | CNY 7.09 | CNY 12 billion | 53.65 |
| Guangdong Feinan | 301500.SZ | 0 % | CNY 21.74 | CNY 11.9 billion | 17.96 |
| Crystal Clear Electronic M | 300655.SZ | 0 % | CNY 10.54 | CNY 11.9 billion | 94.80 |
| Guangdong Baolihua New | 000690.SZ | 0 % | CNY 5.48 | CNY 11.9 billion | 11.00 |
| Yuan Longping High‑Tech | 000998.SZ | 0 % | CNY 8.16 | CNY 11.9 billion | 205.03 |
All five listed peers showed no price movement during the same 24‑hour interval.
Company Overview
Ascentage Pharma Group International is a clinical‑stage biotechnology firm focused on developing novel therapies for a range of diseases, including cancers, hepatitis B virus, and age‑related conditions. The company is headquartered in Suzhou, China, and conducts operations in China, the United States, and other countries. Ascentage Pharma Group International is listed on the Hong Kong Stock Exchange. Official corporate information can be found at www.ascentagepharma.com .
